Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD
1.680
-0.090 (-5.08%)
At close: Jul 19, 2024, 4:00 PM
1.682
+0.002 (0.12%)
After-hours: Jul 19, 2024, 6:51 PM EDT
-5.08%
Market Cap 2.74M
Revenue (ttm) n/a
Net Income (ttm) -8.96M
Shares Out 1.63M
EPS (ttm) -35.39
PE Ratio n/a
Forward PE 7.79
Dividend n/a
Ex-Dividend Date n/a
Volume 336,495
Open 1.750
Previous Close 1.770
Day's Range 1.600 - 1.950
52-Week Range 1.600 - 28.200
Beta 0.22
Analysts n/a
Price Target n/a
Earnings Date Aug 9, 2024

About REVB

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 9
Stock Exchange NASDAQ
Ticker Symbol REVB
Full Company Profile

Financial Performance

Financial Statements

News

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power o...

27 days ago - Business Wire

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power o...

5 weeks ago - Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power o...

2 months ago - Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power o...

4 months ago - Business Wire

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”) a clinical-stage life sciences company that is focused on harnessing the power of ...

4 months ago - Business Wire

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of t...

4 months ago - Business Wire

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”) a clinical-stage life sciences company that is focused on harnessing the power of ...

4 months ago - Business Wire

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, as part of a limited number of accepted abstract authors, t...

5 months ago - Business Wire

Top 5 Health Care Stocks That Are Preparing To Pump In February

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: BIOLCNSPGILDZLAB
5 months ago - Benzinga

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immuni...

5 months ago - Business Wire

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immuni...

6 months ago - Business Wire

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that new preclinical data on the potential therapeutic benefit of...

6 months ago - Business Wire

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on January 25, 2024, the Company will implement a 1-for-30 ...

6 months ago - Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immun...

8 months ago - Business Wire

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that data from recent preclinical studies of the Company's Gemini...

10 months ago - Business Wire

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immuni...

10 months ago - Business Wire

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

10 months ago - Business Wire

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

1 year ago - Business Wire

REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

1 year ago - Business Wire

Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

1 year ago - Business Wire

Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

1 year ago - Business Wire

Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based t...

1 year ago - Business Wire

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based t...

1 year ago - Business Wire

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based t...

1 year ago - Business Wire

Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering

SAN DIEGO--(BUSINESS WIRE)-- #biotechnews--Revelation Biosciences Inc.

1 year ago - Business Wire